This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Immunitas Therapeutics, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Frano Irvine: Innovator in Antibody Therapeutics
Introduction
Frano Irvine is a notable inventor based in Medford, MA (US), recognized for his contributions to the field of antibody therapeutics. He holds 2 patents that focus on innovative treatments for disorders associated with CD161, particularly in the context of certain cancers.
Latest Patents
Irvine's latest patents include the invention of anti-CD161 antibodies and their uses. This invention relates to the development of pharmaceutical compositions that comprise these antibodies, as well as methods for utilizing them to treat disorders mediated by CD161. The patents also cover expression vectors and host cells designed for the production of these antibodies, showcasing a significant advancement in therapeutic options for cancer treatment.
Career Highlights
Frano Irvine is currently associated with Immunitas Therapeutics, Inc., where he continues to push the boundaries of research in antibody therapies. His work is pivotal in the ongoing quest to develop effective treatments for challenging medical conditions.
Collaborations
Irvine collaborates with talented professionals in his field, including Alison Tisdale and Emily Rosentrater. These partnerships enhance the innovative potential of his research and contribute to the advancement of therapeutic solutions.
Conclusion
Frano Irvine's work in the development of anti-CD161 antibodies represents a significant contribution to the field of cancer therapeutics. His innovative approach and collaboration with other experts highlight the importance of teamwork in advancing medical science.